Global Biotechnology Industry Profile & Value Chain Analysis

Global Biotechnology Industry Profile & Value Chain Analysis

Summary

Global Biotechnology industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

The value chain analysis reveals the business activities which comprise the global biotechnology industry value chain. All key stages are highlighted, along with examples of companies active, and assessments of the burning issues for every stage of the value chain. Key value chain stages analyzed include raw materials, chemicals, biotechnology producers, and B2B end users.

Synopsis

Essential resource for top-line data and analysis covering the global biotechnology industry. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key Highlights

- The biotechnology industry consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The global biotechnology industry had total revenues of $353.9bn in 2016, representing a compound annual growth rate (CAGR) of 8.8% between 2012 and 2016.
- The medical/healthcare segment was the industrys most lucrative in 2016, with total revenues of $202.3bn, equivalent to 57.2% of the industrys overall value.
- Globally, the biotechnology industry is driven by the US and Asia-Pacific which make up 46.5% and 24.9% respectively.
- Biotechnology’s wide applications mean it has various B2B End-users. The main verticals are healthcare, agriculture, consumer products and industrial manufacturing

Market Forecast

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology industry
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global biotechnology industry
- Leading company profiles reveal details of key biotechnology industry players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the global biotechnology industry with five year forecasts
- Quickly and easily identify the key stages and sub-stages of the global biotechnology industry value chain
- See examples of companies active at each stage of the global biotechnology industry value chain
- Examine trends and burning issues impacting the global biotechnology industry value chain

Reasons to buy

- What was the size of the global biotechnology industry by value in 2016?
- What will be the size of the global biotechnology industry in 2021?
- What factors are affecting the strength of competition in the global biotechnology industry?
- How has the market performed over the last five years?
- What are the main segments that make up the global biotechnology industry?
- What are the key stages of the global biotechnology industry value chain?


Executive Summary 2
Value chain analysis 2
Market value 2
Market value forecast 2
Category segmentation 2
Geography segmentation 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Value Chain Analysis 8
Biotechnology industry complete value chain overview 8
Raw Materials 10
Suppliers 12
Biotechnology Producers 14
B2B End-users 16
Market Data 18
Market value 18
Market Segmentation 19
Category segmentation 19
Geography segmentation 20
Market Outlook 21
Market value forecast 21
Five Forces Analysis 22
Summary 22
Buyer power 23
Supplier power 24
New entrants 25
Threat of substitutes 27
Degree of rivalry 28
Leading Companies 29
Amgen, Inc. 29
Covance Inc. 32
F. Hoffmann-La Roche Ltd 33
Merck & Co., Inc. 36
Methodology 39
Industry associations 40
Related MarketLine research 40
Appendix 41
About MarketLine 41


List Of Tables

List of Tables
Table 1: Global biotechnology industry value: $ billion, 2012-16 18
Table 2: Global biotechnology industry category segmentation: $ billion, 2016 19
Table 3: Global biotechnology industry geography segmentation: $ billion, 2016 20
Table 4: Global biotechnology industry value forecast: $ billion, 2016-21 21
Table 5: Amgen, Inc.: key facts 29
Table 6: Amgen, Inc.: key financials ($) 30
Table 7: Amgen, Inc.: key financial ratios 30
Table 8: Covance Inc.: key facts 32
Table 9: F. Hoffmann-La Roche Ltd: key facts 33
Table 10: F. Hoffmann-La Roche Ltd: key financials ($) 34
Table 11: F. Hoffmann-La Roche Ltd: key financials (CHF) 34
Table 12: F. Hoffmann-La Roche Ltd: key financial ratios 34
Table 13: Merck & Co., Inc.: key facts 36
Table 14: Merck & Co., Inc.: key financials ($) 37
Table 15: Merck & Co., Inc.: key financial ratios 37


List Of Figures

List of Figures
Figure 1: Biotechnology industry complete value chain overview 8
Figure 2: Biotechnology industry complete value chain with active companies 9
Figure 3: Raw Materials - Overview 10
Figure 4: Suppliers - Overview 12
Figure 5: Biotechnology Producers - Overview 14
Figure 6: B2B End-users - Overview 16
Figure 7: Global biotechnology industry value: $ billion, 2012-16 18
Figure 8: Global biotechnology industry category segmentation: % share, by value, 2016 19
Figure 9: Global biotechnology industry geography segmentation: % share, by value, 2016 20
Figure 10: Global biotechnology industry value forecast: $ billion, 2016-21 21
Figure 11: Forces driving competition in the global biotechnology industry, 2016 22
Figure 12: Drivers of buyer power in the global biotechnology industry, 2016 23
Figure 13: Drivers of supplier power in the global biotechnology industry, 2016 24
Figure 14: Factors influencing the likelihood of new entrants in the global biotechnology industry, 2016 25
Figure 15: Factors influencing the threat of substitutes in the global biotechnology industry, 2016 27
Figure 16: Drivers of degree of rivalry in the global biotechnology industry, 2016 28
Figure 17: Amgen, Inc.: revenues & profitability 31
Figure 18: Amgen, Inc.: assets & liabilities 31
Figure 19: F. Hoffmann-La Roche Ltd: revenues & profitability 35
Figure 20: F. Hoffmann-La Roche Ltd: assets & liabilities 35
Figure 21: Merck & Co., Inc.: revenues & profitability 37
Figure 22: Merck & Co., Inc.: assets & liabilities 38


2021 United Therapeutics Strategic SWOT Analysis--Performance, Capabilities, Goals and Strategies in the Global Biotechnology Industry

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.The report provides significant competitor information, analysis and insight critical to the

USD 750 View Report

2021 Seattle Genetics Strategic SWOT Analysis--Performance, Capabilities, Goals and Strategies in the Global Biotechnology Industry

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.The report provides significant competitor information, analysis and insight critical to the

USD 750 View Report

2021 United Therapeutics Strategic SWOT Analysis--Performance, Capabilities, Goals and Strategies in the Global Biotechnology Industry

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.The report provides significant competitor information, analysis and insight critical to the

USD 750 View Report

2021 Seattle Genetics Strategic SWOT Analysis--Performance, Capabilities, Goals and Strategies in the Global Biotechnology Industry

This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.The report provides significant competitor information, analysis and insight critical to the

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

  Nivi

Thank you for offering us customization services at a minimal cost! We’ll surely recommend your services to others.



  Maxie

Being a primarily sales-based firm, the report available in syndicated form helped us save time on research and focus on our actions. We look forward to working with Aarkstore again!